|
1
|
Khenchouche A, Sadouki N, Boudriche A,
Houali K, Graba A, Ooka T and Bouguermouh A: Human papillomavirus
and Epstein-Barr virus co-infection in cervical carcinoma in
Algerian women. Virol J. 10:3402013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Thomison J III, Thomas LK and Shroyer KR:
Human papillomavirus: molecular and cytologic/histologic aspects
related to cervical intraepithelial neoplasia and carcinoma. Hum
Pathol. 39:154–166. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xiao S, Liao S, Zhou Y, Jiang B, Li Y and
Xue M: High expression of octamer transcription factor 1 in
cervical cancer. Oncol Lett. 7:1889–1894. 2014.PubMed/NCBI
|
|
4
|
Zou JX, Revenko AS, Li LB, Gemo AT and
Chen HW: ANCCA, an estrogen-regulated AAA+ ATPase coactivator for
ERalpha, is required for coregulator occupancy and chromatin
modification. Proc Natl Acad Sci USA. 104:18067–18072. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Boussouar F, Jamshidikia M and Morozumi Y:
Malignant genome reprogramming by ATAD2. Biochim Biophys Acta.
10:1010–1014. 2013. View Article : Google Scholar
|
|
6
|
Ciró M, Prosperini E, Quarto M, Grazini U,
Walfridsson J, McBlane F, Nucifero P, Pacchiana G, Capra M,
Christensen J, et al: ATAD2 is a novel cofactor for MYC,
overexpressed and amplified in aggressive tumors. Cancer Res.
69:8491–8498. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wu G, Lu X, Wang Y, He H, Meng X, Xia S,
Zhen K and Liu Y: Epigenetic high regulation of ATAD2 regulates the
Hh pathway in human hepatocellular carcinoma. Int J Oncol.
45:351–361. 2014.PubMed/NCBI
|
|
8
|
Revenko AS, Kalashnikova EV, Gemo AT, Zou
JX and Chen HW: Chromatin loading of E2F-MLL complex by
cancer-associated coregulator ANCCA via reading a specific histone
mark. Mol Cell Biol. 30:5260–5272. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hsia EY, Kalashnikova EV, Revenko AS, Zou
JX, Borowsky AD and Chen HW: Deregulated E2F and the AAA+
coregulator ANCCA drive proto-oncogene ACTR/AIB1 overexpression in
breast cancer. Mol Cancer Res. 8:183–193. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wan WN, Zhang YX, Wang XM, Liu YJ, Zhang
YQ, Que YH and Zhao WJ: ATAD2 is highly expressed in ovarian
carcinomas and indicates poor prognosis. Asian Pac J Cancer Prev.
15:2777–2783. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Raeder MB, Birkeland E, Trovik J, Krakstad
C, Shehata S, Schumacher S, Zack TI, Krohn A, Werner HM, Moody SE,
et al: Integrated genomic analysis of the 8q24 amplification in
endometrial cancers identifies ATAD2 as essential to MYC-dependent
cancers. PLoS One. 8:e548732013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang Y, Sun Y, Li Y, Fang Z, Wang R, Pan
Y, Hu H, Luo X, Ye T, Li H, et al: ANCCA protein expression is a
novel independent poor prognostic marker in surgically resected
lung adenocarcinoma. Ann Surg Oncol. 20(Suppl 3): S577–S582. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wu G, Liu H, He H, Wang Y, Lu X, Yu Y, Xia
S, Meng X and Liu Y: miR-372 down-regulates the oncogene ATAD2 to
influence hepatocellular carcinoma proliferation and metastasis.
BMC Cancer. 14:1072014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Alizadeh AA, Eisen MB, Davis RE, Ma C,
Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, et al:
Distinct types of diffuse large B-cell lymphoma identified by gene
expression profiling. Nature. 403:503–511. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Creech GS, Paresi C, Li YM and Danishefsky
SJ: Chemical synthesis of the ATAD2 bromodomain. Proc Natl Acad Sci
USA. 111:2891–2896. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang P, Guo L, Duan ZJ, Tepper CG, Xue L,
Chen X, Kung HJ, Gao AC, Zou JX and Chen HW: Histone
methyltransferase NSD2/MMSET mediates constitutive NF-κB signaling
for cancer cell proliferation, survival, and tumor growth via a
feed-forward loop. Mol Cell Biol. 32:3121–3131. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dhalluin C, Carlson JE, Zeng L, He C,
Aggarwal AK and Zhou MM: Structure and ligand of a histone
acetyltransferase bromodomain. Nature. 399:491–496. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jacobson RH, Ladurner AG, King DS and
Tjian R: Structure and function of a human TAFII250 double
bromodomain module. Science. 288:1422–1425. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shahbazian MD and Grunstein M: Functions
of site-specific histone acetylation and deacetylation. Annu Rev
Biochem. 76:75–100. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zou JX, Guo L, Revenko AS, Tepper CG, Gemo
AT, Kung HJ and Chen HW: Androgen-induced coactivator ANCCA
mediates specific androgen receptor signaling in prostate cancer.
Cancer Res. 69:3339–3346. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Caron C, Lestrat C, Marsal S, Escoffer E,
Curtet S, Virolle V, Barbry P, Debernardi A, Brambilla C, Brambilla
E, et al: Functional characterization of ATAD2 as a new
cancer/testis factor and a predictor of poor prognosis in breast
and lung cancers. Oncogene. 29:5171–5181. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kalashnikova EV, Revenko AS, Gemo AT,
Andrews NP, Tepper CG, Zou JX, Cardiff RD, Borowsky AD and Chen HW:
ANCCA/ATAD2 overexpression identifies breast cancer patients with
poor prognosis, acting to drive proliferation and survival of
triple-negative cells through control of B-Myb and EZH2. Cancer
Res. 70:9402–9412. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fouret R, Laffaire J, Hofman P,
Beau-Faller M, Mazieres J, Validire P, Girard P, Camilleri-Bröet S,
Vaylet F, Leroy-Ladurie F, et al: A comparative and integrative
approach identifies ATPase family, AAA domain containing 2 as a
likely driver of cell proliferation in lung adenocarcinoma. Clin
Cancer Res. 18:5606–5616. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hsia EY, Zou JX and Chen HW: The roles and
action mechanisms of p160/SRC coactivators and the ANCCA
coregulator in cancer. Prog Mol Biol Transl Sci. 87:261–298. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Duan Z, Zou JX, Yang P, Wang Y, Borowsky
AD, Gao AC and Chen HW: Developmental and androgenic regulation of
chromatin regulators EZH2 and ANCCA/ATAD2 in the prostate via MLL
histone methylase complex. Prostate. 73:455–466. 2013. View Article : Google Scholar
|
|
26
|
Zhou Y, Sui C, Li B, Yin Z, Tan Y, Yang J
and Liu Z: Repeat hepatectomy for recurrent hepatocellular
carcinoma: a local experience and a systematic review. World J Surg
Oncol. 8:552010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
De Angelis PM, Svendsrud DH, Kravik KL and
Stokke T: Cellular response to 5-fuorouracil (5-FU) in
5-FU-resistant colon cancer cell lines during treatment and
recovery. Mol Cancer. 5:202006. View Article : Google Scholar
|
|
28
|
Zhang L, Hao Q, Bao L, Liu W, Fu X, Chen Y
and Wu H: Phenethyl issothiocyanate suppresses cervical carcinoma
metastasis potential and its molecular mechanism. Mol Med Rep.
10:2675–2680. 2014.PubMed/NCBI
|
